Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe

Croatian Medical Journal

Volumn 57, Issue 5, 2016, Pages 442-456

  Lazarus, Jeffrey V ^a,b   Sperle, Ida ^a   Spina, Alexander ^c   Rockstroh, Jürgen K ^d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^c AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY   (Austria)

^d UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DATA EXTRACTION; EUROPE; FRANCE; GERMANY; HEALTH CARE; HEPATITIS B; HEPATITIS C; HUMAN; ITALY; MEN WHO HAVE SEX WITH MEN; MIGRANT; NETHERLANDS; PRISONER; REVIEW; UNITED KINGDOM; WORLD HEALTH ORGANIZATION; EPIDEMIOLOGY; MALE; MASS SCREENING;

EUROPE; HEPATITIS B; HEPATITIS C; HUMANS; MALE; MASS SCREENING; WORLD HEALTH ORGANIZATION;

EID: 84998567509     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2016.57.442     Document Type: Review

References (161)

1. World health organization. Prevention and control of viral hepatitis infection: Framework for global action. geneva: 2012
2. World health organization. hepatitis c. Fact sheet n. 164. geneva: 2014
3. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. global and regional mortality from 235 causes of death for 20. age groups in 1990 and 2010: a systematic analysis for the global Burden of disease Study 2010. Lancet. 2012;380:2095-128. Medline:23245604 doi:10.1016/S0140-6736(12)61728-0
4. Hatzakis A, Wait S, Bruix J, Buti M, Carballo M, Cavaleri M, et al. the state of hepatitis B and cin europe: report from the hepatitis B and csummit conference. J Viral hepat. 2011;18:1-16. Medline:21824223 doi:10.1111/j.1365-2893.2011.01499.x
5. HIrnschall G. Who's response to hIV/AIdS and viral hepatitis in the european region [speech]. Barcelona, Spain. hephIV. 2014;2014:6
6. Hope VD, Eramova I, Capurro D, Donoghoe MC. Prevalence and estimation of hepatitis B and cinfections in the Who european Region: a review of data focusing on the countries outside the european union and the european Free trade Association. epidemiol Infect. 2014;142:270-86.Medline:23714072 doi:10.1017/S0950268813000940
7. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. global epidemiology and genotype distribution of the hepatitis c virus infection. J hepatol. 2014;61:S45-57.Medline:25086286 doi:10.1016/j.jhep.2014.07.027
8. Hahné SJ, Veldhuijzen IK, Wiessing L, Lim T-A, Salminen M, van de Laar M. Infection with hepatitis B and cvirus In europe: a systematic review of prevalence and cost-effectiveness of screening. BMcInfect dis. 2013;13:181.Medline:23597411 doi:10.1186/1471-2334-13-181
9. World health organization Regional office for europe. Action plan for the health sector response to viral hepatitis in the Who european Region. copenhagen: 2016
10. European centre for disease Prevention and control. hepatitis B and cin the euneighbourhood: prevalence, burden of disease and screening policies. Stockholm: 2010
11. Schweitzer A, Horn J, Mikolajczyk Rt, Krause g, ott JJ. estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546-55.Medline:26231459 doi:10.1016/S0140-6736(15)61412-x
12. Dolan K, Wirtz AL, Moazen B, nDeffo-Mbah M, Galvani A, Kinner SA, et al. global burden of hIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016;388:1089-102. Medline:27427453 doi:10.1016/S0140-6736(16)30466-4
13. World health organization Regional office for europe. Prisons and health. copenhagen: 2014
14. Liaw Y-F. natural history of chronic hepatitis B virus infection and long-term outcome under treatment. Liver Int. 2009;29:100-7. Medline:19207972 doi:10.1111/j.1478-3231.2008.01941.x
15. Kumar S, Jacobson IM. Antiviral therapy with nucleotide polymerase inhibitors for chronic hepatitis c. J hepatol. 2014;61:S91-7.Medline:25443349 doi:10.1016/j.jhep.2014.09.006
16. World health organization. Improving the health of patients with viral hepatitis: report by the Secretariat. geneva: 2013
17. Merkinaite S, Lazarus JV, Gore C. Addressing hcV infection in europe, reported, estimated and undiagnosed cases. cent eur J Public health. 2008;16:106-10.Medline:18935772
18. Liberati A, Altman dg, Tetzlaff J, Mulrow c, grtzsche Pc, Ioannidis JPA, et al. the PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. Medline:19622552 doi:10.1136/bmj.b2700
19. Wiessing L, Ferri M, Grady B, Kantzanou M, Sperle I, Cullen KJ, et al. hepatitis cvirus infection epidemiology among people whO inject drugs in europe: a systematic review of data for scaling up treatment and prevention. PLoS one. 2014;9:e103345. Medline:25068274 doi:10.1371/journal.pone.0103345
20. Abou-Saleh M, Davis P, Rice P, Checinski K, Drummond C, Maxwell D, et al. the effectiveness of behavioural interventions in the primary prevention of hepatitis camongst injecting drug users: a randomised controlled trial and lessons learned. harm Reduct J. 2008;5:25.Medline:18671853 doi:10.1186/1477-7517-5-25
21. Anderson eM, Mandeville RP, Hutchinson SJ, Cameron SO, Mills PR, Fox R, et al. evaluation of a general practice based hepatitis cvirus screening intervention. Scott Med J. 2009;54:3-7. Medline:19728405 doi:10.1258/rsmsmj.54.3.3
22. Blomé MA, Björkman P, Flamholc L, Jacobsson H, Molnegren V, Widell A. Minimal transmission of hIV despite persistently high transmission of hepatitis cvirus in a Swedish needle exchange program: hcV in a needle exchange program. J Viral hepat. 2011;18:831-9.Medline:21114587 doi:10.1111/j.1365-2893.2010.01400.x
23. Brant LJ, Ramsay ME, Balogun MA, Boxall E, Hale A, Hurrelle M, et al. diagnosis of acute hepatitis cvirus infection and estimated incidence in low-and high-risk english populations: acute hcV diagnosis and incidence. J Viral hepat. 2008;15:871-7. Medline:18637073 doi:10.1111/j.1365-2893.2008.01009.x
24. Craine N, Parry J, O'toole J, D'Arcy S, Lyons M. Improving bloodborne viral diagnosis: clinical audit of the uptake of dried blood spot testing offered by a substance misuse service. J Viral hepat. 2009;16:219-22.Medline:19175879 doi:10.1111/j.1365-2893.2008.01061.x
25. Craine N, Hickman M, Parry JV, Smith J, Walker AM, Russell D, et al. Incidence of hepatitis cin drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size. epidemiol Infect. 2009;137:1255.Medline:19224654 doi:10.1017/S095026880900212x
26. Curcio F, Villano G, Masucci S, Plenzik M, Veneruso C, de Rosa G. epidemiological survey of hepatitis c virus infection in a cohort of patients from a ser. t in naples, Italy. J AdDict Med. 2011;5:43-9. Medline:21769046 doi:10.1097/AdM.0b013e3181d131e0
27. Demetriou VL, van de Vijver dA, Hezka J, Kostrikis Lg. hepatitis cinfection among intravenous drug users attending therapy programs in cyprus. J Med Virol. 2010;82:263-70. Medline:20029809 doi:10.1002/jmv.21690
28. Foucher J, Reiller B, Jullien V, Léal F, di Cesare eS, Merrouche W, et al. FibroScan used in street-based outreach for drug users is useful for hepatitis cvirus screening and management: a prospective study. J Viral hepat. 2009;16:121-31.Medline:19175876 doi:10.1111/j.1365-2893.2008.01050.x
29. Hope V, Kimber J, Vickerman P, Hickman M, Ncube F. Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in england. BMcInfect dis. 2008;8:120.Medline:18801177 doi:10.1186/1471-2334-8-120
30. Hope V, Parry JV, Marongui A, Ncube F. hepatitis cinfection among recent initiates to injecting in england 2000-2008: Is a national hepatitis caction plan making a difference? J Viral hepat. 2012;19:55-64.Medline:22187945 doi:10.1111/j.1365-2893.2010.01415.x
31. Hope VD, Hickman M, Ngui SL, Jones S, Telfer M, Bizzarri M, et al. Measuring the incidence, prevalence and genetic relatedness of hepatitis cinfections among a community recruited sample of injecting drug users, using dried blood spots. J Viral hepat. 2011;18:262-70.Medline:20456636 doi:10.1111/j.1365-2893.2010.01297.x
32. Jauffret-Roustide M, Le Strat Y, Couturier E, Thierry D, Rondy M, Quaglia M, et al. A national cross-sectional study among drugusers in France: epidemiology of hcV and highlight on practical and statistical aspects of the design. BMcInfect dis. 2009;9:113. Medline:19607712 doi:10.1186/1471-2334-9-113
33. Lidman C, Norden L, Kaberg M, Käll K, Franck J, Aleman S, et al. hepatitis cinfection among injection drug users in Stockholm Sweden: prevalence and gender. Scand J Infect dis. 2009;41:679-84.Medline:19521924 doi:10.1080/00365540903062143
34. Lindenburg ceA, Lambers FAe, Urbanus At, Schinkel J, Jansen PLM, Krol A, et al. hepatitis ctesting and treatment among active drug users in Amsterdam: results from the dutch-cproject. eur J gastroenterol hepatol. 2011;23:23-31.Medline:21042221 doi:10.1097/Meg.0b013e328340c451
35. Loebstein R, Mahagna R, Maor Y, Kumik D, Elbaz E, Halkin H, et al. hepatitis c, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors. Isr Med Assoc J. 2008;10:775.Medline:19070285
36. Mcdonald SA, Hutchinson SJ, Cameron SO, Innes hA, McLeod A, Goldberg dJ. examination of the risk of reinfection with hepatitis camong injecting drug users who have been tested in glasgow. Int J drug Policy. 2012;23:353-7.Medline:22421553 doi:10.1016/j. drugpo.2012.02.003
37. Mössner BK, Skamling M, Jørgensen tR, Georgsen J, Pedersen C, Christensen PB. decline in hepatitis B infection observed after 11 years of regional vaccination among danisH drug users. J Med Virol. 2010;82:1635-9.Medline:20827758 doi:10.1002/jmv.21836
38. O'Leary MC, Hutchinson SJ, Allen E, Palmateer N, Cameron S, Taylor A, et al. the association between alcohol use and hepatitis cstatus among injecting drug users in glasgow. drug Alcohol depend. 2012;123:180-9.Medline:22137645 doi:10.1016/j. drugalcdep.2011.11.008
39. Schreuder I, van der Sande MA, de Wit M, Bongaerts M, Boucher cA, croes eA, et al. Seroprevalence of hIV, hepatitis B, and hepatitis camong opioid drug users on methadone treatment in the netherlands. harm Reduct J. 2010;7:25.Medline:20977742 doi:10.1186/1477-7517-7-25
40. Senn O, Seidenberg A, Rosemann T. determinants of successful chronic hepatitis ccase finding among patients receiving opioid maintenance treatment in a primary care setting. Addiction. 2009;104:2033-8.Medline:19922570 doi:10.1111/j.1360-0443.2009.02766.x
41. Stephens B. Is it worth testing unstable drug users for hepatitis c? London: British Association for the Study of the Liver Annual Meeting 7-9 September 2011:Poster P68
42. Tait J, Stephens B, McIntyre P, Evans M, Dillon J. dry blood spot testing for hepatitis cin people who inject drugs: reaching the populations other tests cannot reach. Amsterdam; 48th Annual meeting of the european Association for the Study of the Liver, 24 April 2013-28 April 2013:Poster 498
43. Van den Berg chSB, van de Laar tJW, Kok A, Zuure FR, Coutinho RA, Prins M. never injected, but hepatitis cvirus-infected: a study among self-declared never-injecting drug users from the Amsterdam cohort Studies. J Viral hepat. 2009;16:568-77. Medline:19243497 doi:10.1111/j.1365-2893.2009.01105.x
44. Van Houdt R, Bruisten SM, Speksnijder AG, Prins M. unexpectedly high proportion of drug users and men having sex with men who develop chronic hepatitis B infection. J hepatol. 2012;57:529-33. Medline:22612997 doi:10.1016/j.jhep.2012.04.030
45. Witteck A, Schmid P, Hensel-Koch K, Thurnheer M, Bruggmann P, Vernazza P. Management of hepatitis cvirus (hcV) infection in drug substitution programs. Swiss Med Wkly. 2011;141:w13193. Medline:21623473
46. Ansemant T, Ornetti P, Garrot J-F, Pascaud F, Tavernier C, Maillefert J-F. usefulness of routine hepatitis cand hepatitis B serology in the diagnosis of recent-onset arthritis: systematic prospective screening in all patients seen by the rheumatologists of a defined area-Brief report. Joint Bone Spine. 2012;79:268-70. Medline:21733731 doi:10.1016/j.jbspin.2011.05.019
47. Arnold dt, Bentham LM, Jacob RP, Lilford RJ, Girling AJ. Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort. BMcFam Pract. 2011;12:9. Medline:21371303 doi:10.1186/1471-2296-12-9
48. Barril G, Castillo I, Arenas MD, Espinosa M, Garcia-Valdecasas J, Garcia-Fernandez N, et al. occult hepatitis cvirus infection among hemodialysis patients. J Am Soc nephrol. 2008;19:2288-92. Medline:18684893 doi:10.1681/ASn.2008030293
49. Bosevska G, Kuzmanovska G, Sikole A, Dzekova-Vidimilski P, Polenakovic M. Screening for hepatitis B, cand hIV infection among patients on haemodialysis (cRoss sectional analysis among patients from two dialysis units in the period January to July 2005). Prilozi. 2009;30:159-74.Medline:20087257
50. Cano J, Cervera R, Berciano M, Villa J, Garcia P, Espinosa J. Screening for hepatitis B virus in a department of clinical oncology in Spain. Stockholm: european cancer congress, 23-27 Sept 2011:Poster 3415
51. Chevaux J-B, Nani A, Oussalah A, Venard V, Bensenane M, Belle A, et al. Prevalence of hepatitis B and cand risk factors for nonvaccination in inflammatory bowel disease patients in northeast France. Inflamm Bowel dis. 2010;16:916-24. Medline:19885908 doi:10.1002/ibd.21147
52. Flisiak R, Halota W, Horban A, Juszczyk J, Pawlowska M, Simon K. Prevalence and risk factors of hcV infection in Poland. eur J gastroenterol hepatol. 2011;23:1213-7.Medline:22002000 doi:10.1097/Meg.0b013e32834d173c
53. Ganczak M, Szych Z. Infections with hBV, hcV and hIV in patients admitted to the neurosurgical department of a teaching hospital. neurol neurochir Pol. 2008;42:231-7.Medline:18651329
54. Ganczak M, Korzen M, Szych Z. Seroprevalence of hepatitis c virus infection among surgical nurses, their patients and blood donation candidates in Poland. J hosp Infect. 2012;82:266-70. Medline:23110996 doi:10.1016/j.jhin.2012.08.021
55. Guennoc X, Narbonne V, Jousse-Joulin S, Devauchelle-Pensec V, Dougados M, Daurcs JP, et al. Is screening for hepatitis B and hepatitis cuseful in patients with recent-onset polyarthritis? the eSPoIR cohort study. J Rheumatol. 2009;36:1407-13. Medline:19531755 doi:10.3899/jrheum.081308
56. Ippolito AM, Niro gA, Fontana R, Lotti g, Gioffreda d, Valvano MR, et al. unawareness of hBV infection among inpatients in a Southern Italian hospital. J Viral hepat. 2011;18:e206-11. Medline:21692934 doi:10.1111/j.1365-2893.2010.01432.x
57. Kakisi oK, Grammatikos AA, Karageorgopoulos de, Athanasoulia AP, Papadopoulou AV, Falagas ME. Prevalence of hepatitis B, hepatitis c, and hIV infections among patients in a psychiatric hospital in greece. Psychiatr Serv. 2009;60:1269-72. Medline:19723746 doi:10.1176/ps.2009.60.9.1269
58. Marcos M, Alvarez F, Brito-Zerón P, Bove A, Perez-de-Lis M, DiazLagares c, et al. chronic hepatitis B virus infection in Sjögren's syndrome. Prevalence and clinical significance in 603 patients. Autoimmun Rev. 2009;8:616-20.Medline:19393197 doi:10.1016/j. autrev.2009.02.007
59. Mcclean H, Carne cA, Sullivan AK, Menon-Johansson A, Gokhale R, Sethi g, et al. national audit of asymptomatic screening in uK genitourinary medicine clinics: case-notes audit. Int J StdAIdS. 2010;21:506-11.Medline:20852202 doi:10.1258/ijsa.2010.009572
60. Muche M, Darstein F, Stein A, Hofmann J, Pfaffenbach S, Somasundaram R. Prevalence and risk factors for hepatitis B and Camong patients attenDing a german emergency department: is a risk assessment questionnaire a useful pre-screening tool? Amsterdam; 48th Annual Meeting of the european Association for the Study of the Liver, 24 April 2013-28 April 2013:Poster 981
61. Okan V, Yilmaz M, Bayram A, Kis C, Cifci S, Buyukhatipoglu H, et al. Prevalence of hepatitis B and cviruses in patients with lymphoproliferative disorders. Int J hematol. 2008;88:403-8. Medline:18836791 doi:10.1007/s12185-008-0175-3
62. Özaslan E, Demirezer A, Yavuz B. occult hepatitis B virus infection in turkish healthy individuals. eur J gastroenterol hepatol. 2009;21:1436-7.Medline:19907228 doi:10.1097/10.1097/Meg.0b013e328321b124
63. Palazzi C, D'Amico E, D'Angelo S, Nucera A, Petricca A, Olivieri I. hepatitis cvirus infection in Italian patients with fibromyalgia. clin Rheumatol. 2008;27:101-3.Medline:17943229 doi:10.1007/s10067-007-0737-4
64. Ross RS, Viazov S, Khudyakov YE, xia gL, Lin Y, Holzmann h, et al. transmission of hepatitis cvirus in an orthopedic hospital ward. J Med Virol. 2009;81:249-57.Medline:19107970 doi:10.1002/jmv.21394
65. Sjöberg K, Widell A, Verbaan H. Prevalence of hepatitis cin Swedish diabetics is low and comparable to that in health care workers. eur J gastroenterol hepatol. 2008;20:135-8.Medline:18188035 doi:10.1097/Meg.0b013e3282f476f5
66. Slavenburg S, Verduyn-Lunel FM, Hermsen JT, Melchers WJG, Te Morsche RHM, Drenth JP. Prevalence of hepatitis cin the general population in the netherlands. neth J Med. 2008;66:13-7. Medline:18219062
67. Spenatto N, Boulinguez S, Mularczyk M, Molinier L, Bureau C, Saune K, et al. hepatitis B screening: who to target? A French sexually transmitted infection clinic experience. J hepatol. 2013;58:690-7.Medline:23220369 doi:10.1016/j.jhep.2012.11.044
68. Tweed E, Brant L, Hurrelle M, Klapper P, Ramsay M; hepatitis Sentinel Surveillance Study group. hepatitis ctesting in sexual health services in england, 2002-7: results from sentinel surveillance. Sex transm Infect. 2010;86:126-30.Medline:19858534 doi:10.1136/sti.2009.036590
69. Vermehren J, Schlosser B, Domke D, Elanjimattom S, Müller C, Hintereder G, et al. high prevalence of anti-hcV antibodies in two metropolitan emergency departments in germany: a prospective screening analysis of 28,809 patients. PLoS one. 2012;7:e41206. Medline:22848445 doi:10.1371/journal.pone.0041206
70. Ydreborg M, Söderström A, Hlkanson A, Alsiö L, Arnholm B, Malmström P, et al. Look-back screening for the identification of transfusion-induced hepatitis cvirus infection in Sweden. Scand J Infect dis. 2011;43:522-7.Medline:21375426 doi:10.3109/0036554 8.2011.562526
71. Balogun MA, Parry JV, Mutton K, Okolo C, Benons L, Baxendale H, et al. hepatitis B virus transmission in pre-adolescent schoolchildren in four multi-ethnic areas of england. epidemiol Infect. 2013;141:916-25.Medline:22849968 doi:10.1017/S0950268812001513
72. Brown AE, Ross DA, Simpson AJH, Erskine RS, Murphy G, Parry JV, et al. Prevalence of markers for hIV, hepatitis B and hepatitis c infection in uK military recruits. epidemiol Infect. 2011;139:1166-71.Medline:21208514 doi:10.1017/S0950268810002712
73. Cai W, Poethko-Müller C, Hamouda O, Radun D. hepatitis B virus infections among children and adolescents in germany: migration background as a risk factor in a low seroprevalence population. Pediatr Infect dis J. 2011;30:19-24.Medline:20683220 doi:10.1097/InF.0b013e3181ef22d5
74. Castillo I, Bartolomé J, Quiroga JA, Barril G, Carreno V. hepatitis c virus infection in the family setting of patients with occult hepatitis c. J Med Virol. 2009;81:1198-203.Medline:19475603 doi:10.1002/jmv.21483
75. Coyne KM, Banks A, Heggie C, Scott CJ, Grover D, Evans C, et al. Sexual health of adults working in pornogrAphic films. Int J StdAIdS. 2009;20:508-9.Medline:19541897 doi:10.1258/ijsa.2008.008434
76. Cuypers WJ, Niekamp AM, Keesmekers R, Spauwen L, Hollman D, Telg D, et al. high prevalence of hIV, other sexually transmitted infections and risk profile in male commercial sex workers who have sex with men in the netherlands. Québec city, canada; 19th Biennial conference of the International Society for Sexually transmitted diseases Research, July 10-13 2011:Poster P1-S2.11
77. Hickman M, Mcdonald T, Judd A, Nichols T, Hope V, Skidmore S, et al. Increasing the uptake of hepatitis cvirus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial. J Viral hepat. 2008;15:250-4. Medline:18086182 doi:10.1111/j.1365-2893.2007.00937.x
78. Karaosmanoglu HK, Aydin OA, Sandikci S, Yamanlar ER, Nazlican O. Seroprevalence of hepatitis B: do blood donors represent the general population? J Infect dev ctries. 2012;6:181-3. Medline:22337848
79. Katsanos KH, Christodoulou DK, Zervou E, Babameto A, Craja B, Hyphantis H, et al. hepatitis B remains a major health priority in Western Balkans: results of a 4-year prospective greekAlbanian collaborative study. eur J Intern Med. 2009;20:698-702. Medline:19818290 doi:10.1016/j.ejim.2009.07.016
80. Meffre C, Le Strat Y, Delarocque-Astagneau E, Dubois F, Antona D, Lemasson J-M, et al. Prevalence of hepatitis B and hepatitis cvirus infections in France in 2004: social factors are important predictors after adjusting for known risk factors. J Med Virol. 2010;82:546-55. Medline:20166185 doi:10.1002/jmv.21734
81. Pazdiora P, Böhmová Z, Kubátová A, Menclová I, Morávková I, Pruchová J, et al. Screening family and sexual contacts of hBsAg+ persons in the Pilsen region. epidemiol Mikrobiol Imunol. 2012;61:51-7.Medline:23173297
82. Resuli B. epidemiology of hepatitis B virus infection in Albania. World J gastroenterol. 2009;15:849.Medline:19230046 doi:10.3748/wjg.15.849
83. Sahajian F, Bailly F, Vanhems P, Fantino B, Vannier-Nitenberg C, Fabry J, et al. A randomized trial of viral hepatitis prevention among underprivileged people in the Lyon area of France. J Public health (oxf). 2011;33:182-92.Medline:20876189 doi:10.1093/pubmed/fdq071
84. Stamouli M, Velonakis E, Panagiotou I, Totos G. Prevalence of hepatitis B among greek naval recruits. Berne, Switzerland. Swiss Medlab. 2012;12-14:c03
85. Taylor A, Hutchinson SJ, Gilchrist G, Cameron S, Carr S, Goldberg DJ. Prevalence and determinants of hepatitis cvirus infection among female drug injecting sex workers in glasgow. harm Reduct J. 2008;5:11.Medline:18355407 doi:10.1186/1477-7517-5-11
86. Tresó B, Barcsay E, tarján A, Horváth G, Dencs Á, Hettmann A, et al. Prevalence and correlates of hcV, hVB, and hIV infection among prison inmates and staff, hungary. J urban health. 2012;89:108-16. Medline:22143408 doi:10.1007/s11524-011-9626-x
87. Trevisan A, Bruno A, Mongillo M, Morandin M, Pantaleoni A, Borella-Venturini M, et al. Prevalence of markers for hepatitis B Virus and Vaccination compliance Among Medical School Students in Italy. Infect control hosp epidemiol. 2008;29:1189-91. Medline:18973454 doi:10.1086/592414
88. Urbanus AT, van den hoek A, Boonstra A, van Houdt R, de Bruijn LJ, Heijman T, et al. People with multiple tattoos and/or piercings are not at increased risk for hBV or hcV in the netherlands. PLoS one. 2011;6:e24736.Medline:21935447 doi:10.1371/journal. pone.0024736
89. Walz A, Wirth S, hucke J, Gerner P. Vertical transmission of hepatitis B virus (hBV) from mothers negative for hBV surface antigen and positive for antibody to hBV core antigen. J Infect dis. 2009;200:1227-31.Medline:19751152 doi:10.1086/605698
90. Zuure FR, Davidovich U, Coutinho RA, Kok G, Hoebe CJPA, van den Hoek A, et al. using mass media and the internet as tools to diagnose hepatitis cinfections in the general population. Am J Prev Med. 2011;40:345-52.Medline:21335268 doi:10.1016/j. amepre.2010.11.019
91. Bissinger A, enders G, Schalasta G, Vergopoulos A, Enders M. Frequency of hepatitis B antigen positive pregnant women with high viral loads detected during routine antenatal care in germany. Amsterdam; 48th Annual meeting of the european Association for the Study of the Liver, 24 April 2013-28 April 2013:Poster 967
92. Bjerke SEY, Vangen S, holter E, Stray-Pedersen B. Infectious immune status in an obstetric population of Pakistani immigrants in norway. Scand J Public health. 2011;39:464-70. Medline:21339369 doi:10.1177/1403494811399653
93. Frischknecht F, Brühwiler H, Sell W, trummer I. Serological testing for infectious diseases in pregnant women: are the guidelines followed? Swiss Med Wkly. 2011;140:w13138.Medline:21213147
94. Gun I, Ertugrul S, Kaya N, Akpak YK. Seroprevalence among turkish pregnant women. health Med. 2012;6:2471
95. Harder KM, cowan S, Eriksen MB, Krarup HB, Christensen PB. universal screening for hepatitis B among pregnant women led to 96% vaccination coverage among newborns of hBsAg positive mothers in denmark. Vaccine. 2011;29:9303-7.Medline:22019756 doi:10.1016/j.vaccine.2011.10.028
96. Heininger U, Vaudaux B, nidecker M, Pfister RE, Posfay-Barbe KM, Bachofner M, et al. evaluation of the compliance with recommended procedures in newborns exposed to hBsAgpositive mothers: a multicenter collaborative study. Pediatr Infect dis J. 2010;29:248-50.Medline:19935120 doi:10.1097/InF.0b013e3181bd7f89
97. HUghes C, Grundy K, Emerson G, Mocanu E. Viral screening at the time of each donation in ARtpatients: is it justified? hum Reprod. 2011;26:3169-72.Medline:21865236 doi:10.1093/humrep/der278
98. Karatapanis S, Skorda L, Marinopoulos S, Papastergiou V, drogosi M, Lisgos P, et al. higher rates of chronic hepatitis B infection and low vaccination-induced protection rates among parturients escaping hBsAg prenatal testing in greece: a 2-year prospective study. eur J gastroenterol hepatol. 2012;24:878-83. Medline:22588307 doi:10.1097/Meg.0b013e328354834f
99. Knorr B, Maul H, Schnitzler P. Prevalence of hepatitis B virus infection among women at reproductive age at a german university hospital. J clin Virol. 2008;42:422-4.Medline:18448387 doi:10.1016/j.jcv.2008.03.009
100. Koruk I, Koruk S, copur Aç, Simsek Z. An intervention study to improve hBsAg testing and preventive practices for hepatitis B in an obstetrics hospital. tAF Prev Med Bull. 2011;10:287-92. doi:10.5455/pmb.20101215040249
101. Kristiansen MG, Eriksen BO, Maltau JM, Holdo B, Gutteberg TJ, Mortensen L, et al. Prevalences of viremic hepatitis cand viremic hepatitis B in pregnant women in northern norway. hepatogastroenterology. 2009;56:1141-5.Medline:19760958
102. Lambert J, Jackson V, Coulter-Smith S, Brennan M, Geary M, Kelleher TB, et al. universal antenatal screening for hepatitis c. Ir Med J. 2013;106:136-9.Medline:23914572
103. Op de Coul EL, Hahné S, van Weert YW, Oomen P, Smit C, van der Ploeg K, et al. Antenatal screening for hIV, hepatitis B and syphilis in the netherlands is effective. BMcInfect dis. 2011;11:185. Medline:21718466 doi:10.1186/1471-2334-11-185
104. Pepas L, MacMahon E, El Toukhy T, Khalaf Y, Braude P. Viral screening before each cycle of assisted conception treatment is expensive and unnecessary: a survey of results from a uK inner city clinic. hum Fertil. 2011;14:224-9.Medline:22088129 doi:10.3109/14 647273.2011.627624
105. Pereira A, Fernandes A, Pinheiro L. Pre-conception and prenatal care in Braga Region. tallinn, estonia: 20th european Workshop on neonatology, 27th-30th June, 2012: Abstract 26
106. Heiligenberg M, van der Loeff M, de Vries H, Geerlings S, Prins M, Prins J. Low prevalence of asymptomatic StI in hIV-infected heterosexual males and females, visiting an hIV outpatient clinic in the netherlands. Québec city, canada; 19th Biennial conference of the International Society for Sexually transmitted diseases Research, July 10-13 2011: Poster P1-S5.27
107. Matser A, Geskus R, hEijman T, Urbanus A, Prins J, de Vries H, et al. Lifestyle as marker of hepatitis cinfection in hIV infected MSM in Amsterdam, the netherlands. Québec city, canada; 19th Biennial conference of the International Society for Sexually transmitted diseases Research, July 10-13 2011:oral 10-04
108. Popivanova N, Boykinova O, Baltadzhiev I, Stoilova Y, Novakor S, Dineva A, et al. human hepatitis viruses B and camong hIVinfected patients-clinical and epidemiological features. Probl Infect Parasit dis. 2009;37:17-9
109. Reuter S, Oette M, Wilhelm FC, Beggel B, Kaiser R, Balduin M, et al. Prevalence and characteristics of hepatitis B and cvirus infections in treatment-naïve hIV-infected patients. Med Microbiol Immunol (Berl). 2011;200:39-49.Medline:20853118 doi:10.1007/s00430-010-0172-z
110. Seme K, Lunar MM, Tomazic J, Vidmar L, Karner P, Maticic M, et al. Low prevalence of hepatitis B and cinfections among hIVinfected individuals in Slovenia: a nation-wide study, 1986-2008. Acta dermatovenerol Alp Pannonica Adriat. 2009;18:153-6. Medline:20043052
111. Steedman NM, McMillan A. hepatitis B testing and vaccination in patients recently diagnosed with hIV infection. Int J StdAIdS. 2008;19:83-4.Medline:18334058 doi:10.1258/ijsa.2007.007144
112. Turner J, Bansi L, Gilson R, Gazzard B, Walsh J, Pillay D, et al. the prevalence of hepatitis cvirus (hcV) infection in hIV-positive individuals in the uK-trends in hcV testing and the impact of hcV on hIV treatment outcomes. J Viral hepat. 2010;17:569-77. Medline:19840365 doi:10.1111/j.1365-2893.2009.01215.x
113. Urbanus AT, van de Laar TJ, Stolte IG, Schinkel J, Heijman T, Coutinho RA, et al. hepatitis cvirus infections among hIV-infected men who have sex with men: an expanding epidemic. AIdS. 2009;23:F1-7.Medline:19542864 doi:10.1097/QAd.0b013e32832e5631
114. Wandeler G, Gsponer T, Bregenzer A, Gunthard HF, Clerc O, Calmy A, et al. hepatitis cvirus infections in the Swiss hIV cohort Study: a rapidly evolving epidemic. clin Infect dis. 2012;55:1408-16. Medline:22893583 doi:10.1093/cid/cis694
115. Winnock M, Bani-Sadr F, Pambrun E, Loko M-A, Lascoux-Combe C, Garipuy D, et al. Prevalence of immunity to hepatitis viruses A and B in a large cohort of hIV/hcV-coinfected patients, and factors associated with hAV and hBV vaccination. Vaccine. 2011;29:8656-60.Medline:21920402 doi:10.1016/j.vaccine.2011.08.125
116. Akcam FZ, Uskun E, Avsar K, Songur Y. hepatitis B virus and hepatitis cvirus seroprevalence in rural areas of the southwestern region of turkey. Int J Infect dis. 2009;13:274-84.Medline:18945630 doi:10.1016/j.ijid.2008.07.005
117. Brant LJ, Hurrelle M, Balogun MA, Klapper P, Ahmad F, Boxall E, et al. Sentinel laboratory surveillance of hepatitis cantibody testing in england: understanding the epidemiology of hcV infection. epidemiol Infect. 2007;135:417.Medline:16836798 doi:10.1017/S0950268806006832
118. Brant LJ, Hurrelle M, Collins S, Klapper PE, Ramsay Me. using automated extraction of hepatitis B tests for surveillance: evidence of decreasing incidence of acute hepatitis B in england. epidemiol Infect. 2012;140:1075-86.Medline:21892985 doi:10.1017/S0950268811001683
119. Brant LJ, Hurrelle M, Balogun MA, Klapper P, Ramsay Me. the hepatitis Sentinel Surveillance Study group. Where are people being tested for anti-hcV in england? Results from sentinel laboratory surveillance. J Viral hepat. 2008;15:729-39. Medline:18637078 doi:10.1111/j.1365-2893.2008.01000.x
120. Cozzolongo R, Osella AR, Elba S, Petruzzi J, Buongiorno G, Giannuzzi V, et al. epidemiology of hcV infection in the general population: a survey in a southern Italian town. Am J gastroenterol. 2009;104:2740-6.Medline:19638964 doi:10.1038/ajg.2009.428
121. Defossez G, Verneau A, Ingrand I, Silvain C, Ingrand P, Beauchant M, et al. evaluation of the French national plan to promote screening and early management of viral hepatitis c, between 1997 and 2003: a comparative cross-sectional study in Poitoucharentes region. eur J gastroenterol hepatol. 2008;20:367-72. Medline:18403936 doi:10.1097/Meg.0b013e3282f479ab
122. Delarocque-Astagneau E, Meffre c, Dubois F, Pioche C, Le Strat Y, Roudot-Thoraval F, et al. the impact of the prevention programme of hepatitis cover more than a decade: the French experience. J Viral hepat. 2010;17:435-43.Medline:19780936 doi:10.1111/j.1365-2893.2009.01196.x
123. Fabris P, Baldo V, Baldovin T, Bellotto E, Rassu M, Trivello R, et al. changing epidemiology of hcV and hBV infections in northern Italy: a survey in the general population. J clin gastroenterol. 2008;42:527-32.Medline:18277889 doi:10.1097/Mcg.0b013e318030e3ab
124. Ozkan S, Atak A, Bozdayi G, Turkcuoglu S, Maral I. communitybased research: cost of the tests used for anti-hBc total seropositivity only and hepatitis B screening. trans R Soc trop Med hyg. 2010;104:782-6.Medline:20889180 doi:10.1016/j. trstmh.2010.08.012
125. Zacharakis G, Kotsiou S, Papoutselis M, Vafiadis N, Tzara F, Pouliou E, et al. changes in the epidemiology of hepatitis B virus infection following the implementation of immunisation programmes in northeastern greece. euro Surveill. 2009;14:pii: 19297. Medline:19679032
126. Acar A, Kemahli S, Altunay H, Kosan E, Oncul O, Gorenek L, et al. the significance of repeat testing in turkish blood donors screened with hBV, hcV anD hIV immunoassays and the importance of S/coratios in the interpretation of hcV/hIV screening test results and as a determinant for further confirmatory testing. transfus Med. 2010;20:152-9.Medline:20059750 doi:10.1111/j.1365-3148.2009.00987.x
127. Dettori S, Candido A, Kondili LA, Chionne P, Taffon S, Genovese D, et al. Identification of low hBV-dnA levels by nucleic acid amplification test (nAt) in blood donors. J Infect. 2009;59:128-33. Medline:19586663 doi:10.1016/j.jinf.2009.06.007
128. Kazmierczak M, Ciebiada M, Pekala-Wojciechowska A, Pawlowski M, Pietras T, Antczak A. Prevalence of viruses hBV, hcV and hIV in blood donors at the Regional centre of Blood donation and Blood treatment in Poznan in the years 2008-2010. Pol Arch Med Wewn. 2014;124:290-7.Medline:24824617
129. Öner S, Yapici G, Sasmaz CT, Kurt Aö, Bugdayci R. hepatitis B, hepatitis c, hIV, and VdRL seroprevalence of blood donors in Mersin, turkey. turk J Med Sci. 2011;41:335-41
130. Romann L, Velati C, Cambic G, Fomiatti L, Galli C, Zanetti AR, et al. hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection. Blood transfus. 2013;11:281.Medline:23399361
131. Wiegand J, Luz B, Mengelkamp A-K, Moog R, Koscielny J, Halmheinrich I, et al. Autologous blood donor screening indicated a lower prevalence of viral hepatitis in east vs West germany: epidemiological benefit from established health resources. J Viral hepat. 2009;16:743-8.Medline:19486277 doi:10.1111/j.1365-2893.2009.01132.x
132. Heidrich B, Cetindere A, Beyaz M, Basaran M, Braynis B, Raupach R, et al. high prevalence of hepatitis marker in immigrant populations: a prospective multicenter screening approach in a real world setting. Barcelona, Spain; 47th annual meeting of the european Association for the Study of the Liver: Poster 987
133. Jafferbhoy H, Miller Mh. McIntyre P, Dillon JF. the effectiveness of outreach testing for hepatitis cin an immigrant Pakistani population. epidemiol Infect. 2012;140:1048-53.Medline:21854668 doi:10.1017/S095026881100152x
134. Lewis H, Burke K, Begum S, Ushiro-Limb I, Foster G. P56 What is the best method of case finding for chronic viral hepatitis in migrant communities? gut. 2011;60 Suppl 2:A26-26. doi:10.1136/gutjnl-2011-300857a.56
135. Milionis C. Serological markers of hepatitis B and camong juvenile immigrants from Albania settled in greece. eur J gen Pract. 2010;16:236-40.Medline:20954813 doi:10.3109/13814788.2010.52 5631
136. Richter C, Beest GT, Sancak I, Aydinly R, Bulbul K, Laetemiatomata F, et al. hepatitis B prevalence in the turkish populatIon of Arnhem: implications for national screening policy? epidemiol Infect. 2012;140:724-30.Medline:21740610 doi:10.1017/S0950268811001270
137. Tramuto F, Mazzucco W, Maida CM, Affronti A, Affronti M, Montalto G, et al. Serological pattern of hepatitis B, c, and hIV infections among immigrants in Sicily: epidemiological aspects and implication on public health. J community health. 2012;37:547-53. Medline:21922163 doi:10.1007/s10900-011-9477-0
138. Veldhuijzen IK, Wolter R, Rijckborst V, Mostert M, Voeten HA, Cheung Y, et al. Identification and treatment of chronic hepatitis B in chinese migrants: Results of a project offering on-site testing in Rotterdam, the netherlands. J hepatol. 2012;57:1171-6. Medline:22885717 doi:10.1016/j.jhep.2012.07.036
139. Veldhuijzen IK, van Driel HF, Vos D, de Zwart O, van Doornum gJJ, de Man RA, et al. Viral hepatitis in a multi-ethnic neighborhood in the netherlands: results of a community-based study in a low prevalence country. Int J Infect dis. 2009;13:e9-13. Medline:18678518 doi:10.1016/j.ijid.2008.05.1224
140. Barros H, Ramos E, Lucas R. A survey of hIV and hcV among female prison inmates in Portugal. cent eur J Public health. 2008;16:116. Medline:18935775
141. Kirwan P, Evans B; Sentinel Surveillance of hepatitis testing Study group, Brant L. hepatitis cand B testing in english prisons is low but increasing. J Public health (oxf). 2011;33:197-204. Medline:21345883 doi:10.1093/pubmed/fdr011
142. Marques NM, Margalho R, Melo MJ, da Cunha JGS, MeliçoSilvestre AA. Seroepidemiological survey of transmissible infectious diseases in a Portuguese prison establishment. Braz J Infect dis. 2011;15:272-5.Medline:21670930 doi:10.1016/S1413-8670(11)70188-x
143. Murray E, Jones D. Audit into blood-borne virus services in her Majesty's Prison Service. Int J StdAIdS. 2008;19:347-8. Medline:18482968 doi:10.1258/ijsa.2007.007205
144. Pontali E, Ferrari F. Prevalence of hepatitis B virus and/or hepatitis cvirus co-infections in prisoners infected with the human Immunodeficiency Virus. Int J Prison health. 2008;4:77-82. Medline:18464061 doi:10.1080/17449200802038207
145. Popov G, Plochev K, Pekova L, Pishmisheva M, Popov T, Tchervenyakova T. Prevalence of viral hepatitis, human immunodeficiency virus and syphilis among inmates of Bulgarian prisons. Amsterdam; 48th Annual meeting of the european Association for the Study of the Liver, 24 April 2013-28 April 2013:Poster 986
146. Verneuil L, Vidal J-S, Ze Bekolo R, Vabret A, Petitjean J, Leclercq R, et al. Prevalence and risk factors of the whole spectrum of sexually transmitted diseases in male incoming prisoners in France. eur J clin Microbiol Infect dis. 2009;28:409-13.Medline:18998176 doi:10.1007/s10096-008-0642-z
147. Slusarczyk J, Malkowski P, Bobilewicz D, Juszczyk G. crosssectional, anonymous screening for asymptomatic hcV infection, immunity to hBV, and occult hBV infection among health care workers in Warsaw, Poland. Przegl epidemiol. 2012;66:445-51. Medline:23230715
148. Topka D, Theodosopoulos L, Elefsiniotis I, Saroglou G, Brokalaki H. Prevalence of hepatitis B in haemodialysis nursing staff in Athens. J Ren care. 2012;38:76-81.Medline:21917123 doi:10.1111/j.1755-6686.2011.00247.x
149. Zaaijer HL, Appelman P, Frijstein G. hepatitis cvirus infection among transmission-prone medical personnel. eur J clin Microbiol Infect dis. 2012;31:1473-7.Medline:22045049 doi:10.1007/s10096-011-1466-9
150. Bozicevic I, Lepej SZ, Rode OD, Grgic I, Jankovic P, Dominkovic Z, et al. Prevalence of hIV and sexually transmitted infections and patterns of recent hIV testing among men who have sex with men in Zagreb, croatia. Sex transm Infect. 2012;88:539-44. Medline:22628664 doi:10.1136/sextrans-2011-050374
151. Di Benedetto MA, di Piazza F, Amodio E, Taormina S, Romano N, Firenze A. Prevalence of sexually transmitted infections and enteric protozoa among homosexual men in western Sicily (south Italy). J Prev Med hyg. 2012;53:181-5.Medline:23469584
152. Platteau T, Wouters K, Apers L, Avonts D, Nöstlinger C, Sergeant M, et al. Voluntary outreach counselling and testing for hIV and StI among men who have sex with men in Antwerp. Acta clin Belg. 2012;67:172-6.Medline:22897064
153. Scott C, Day S, Low E, Sullivan A, Atkins M, Asboe D. unselected hepatitis cscreening of men who have sex with men attending sexual health clinics. J Infect. 2010;60:351-3.Medline:20153770 doi:10.1016/j.jinf.2010.01.013
154. Boot HJ, Hahné S, Cremer J, Wong A, Boland G, Van Loon AM. Persistent and transient hepatitis B virus (hBV) infections in children born to hBV-infected mothers despite active and passive vaccination: perinatal hBV transmission. J Viral hepat. 2010;17:872-8.Medline:20051008 doi:10.1111/j.1365-2893.2009.01247.x
155. Bracciale L, Fabbiani M, Sansoni A, Luzzi L, Bernini L, Zanelli G. Impact of hepatitis B vaccination in children born to hBsAgpositive mothers: a 20-year retrospective study. Infection. 2009;37:340-3.Medline:19629385 doi:10.1007/s15010-008-8252-3
156. Hahné S, van den hoek A, Baayen D, van der Sande M, de Melker H, Boot H. Prevention of perinatal hepatitis B virus transmission in the netherlands, 2003-2007: children of chinese mothers are at increased risk of breakthrough infectiOn. Vaccine. 2012;30:1715-20. Medline:22210140 doi:10.1016/j.vaccine.2011.12.071
157. Eurostat. Migration and migrant population statistics. Available from: http://ec.europa.eu/eurostat/statistics-explained/index.php/Migration_and_migrant_population_statistics. Accessed: May 4, 2015
158. Rossi C, Shrier I, Marshall L, Cnossen S, Schwartzman K, Klein MB, et al. Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis. PLoS one. 2012;7:e44611.Medline:22957088 doi:10.1371/journal.pone.0044611
159. European centre for disease Prevention and control. ecdc technical report: assessing the burden of key infectious diseases affecting migrant populations in the eu/eeA. Stockholm: 2014
160. Vriend HJ, Van Veen MG, Prins M, Urbanus AT, Boot HJ, Op de Coul EL. hepatitis cvirus prevalence in the netherlands: migrants account for most infections. epidemiol Infect. 2013;141:1310-7. Medline:22963908 doi:10.1017/S0950268812001884
161. Roux P, Sagaon-Teyssier L, Lions C, Fugon L, Verger P, Carrieri MP. hcV seropositivity in inmates and in the general population: an averaging approach to establish priority prevention interventions. BMJ open. 2014;4:e005694.Medline:25331969 doi:10.1136/bmjopen-2014-005694